State Court Panel Signs Order Coordinating Bextra Cases

NEW YORK - More than 60 claims alleging injury caused by ingestion of the withdrawn arthritis drug Bextra have been coordinated before a single judge in New York. Kelly v. Pfizer Inc., No. 102893/2005 (N.Y. Sup. Ct., New York Cty.).

According to a decision and order released Dec. 1, the New York Litigation Coordinating Panel said the state court Bextra cases will be centralized in the New York County Supreme Court. The decision follows a request by seven plaintiffs' firms, who represent plaintiffs allegedly injured as a result of taking Bextra, and earlier this year joined an application to coordinate …